-
BeiGene responds to AbbVie's lawsuit alleging theft of trade secrets: with the intention of obstructing the development process
Blue Whale News, September 12th (Reporter Tu Jun) Following the patent infringement lawsuit filed by AbbVie in June last year regarding its core product BTK inhibitor Baiyueze (Zebutinib Capsules), i ... -
BeiGene denies AbbVie's accusation of "stealing trade secrets": will launch a firm defense and development projects will not be interrupted as a result
On September 12th, the A-share price of BeiGene (SH688235, stock price 144.01 yuan, market value 198.44 billion yuan) fell sharply by 10.61%. On the afternoon of the 12th, BeiGene told the Daily Econ ...